Table 1
Prevalent cases of self‑reported diseases in individuals aged ≥18 years in Bogotá, 2022–2023.
| PREVALENCE OF SELF‑REPORTED DISEASE | FREQUENCY | PERCENTAGE |
|---|---|---|
| Total population | 5,410,337 | 100.0% |
| Heart disease | 274,364 | 5.1% |
| High blood pressure | 1,239,532 | 22.9% |
| High cholesterol level | 550,438 | 10.2% |
| Type 2 diabetes | 406,322 | 7.5% |
| Gastroesophageal reflux | 32,265 | 6.0% |
| Gout | 3,038 | 0.6% |
| Other diseases | 2,799,972 | 51.8% |
[i] Source: authors.
Table 2
Prevalence of diabetes, metabolic syndrome, abdominal obesity and other related conditions in the population aged ≥in 18 years in Bogotá (Colombia) 2022–2023.
| PREVALENCE | ESTIMATION | STANDARD ERROR | 95% CONFIDENCE INTERVAL | RELATIVE STANDARD ERROR | DESIGN EFFECT | |
|---|---|---|---|---|---|---|
| LOWER | UPPER | |||||
| Diabetes | 11.0% | 1.20% | 9.0% | 13.5% | 0.105 | 1.446 |
| Metabolic syndrome, ATP III | 33.9% | 2.30% | 29.5% | 38.6% | 0.068 | 2.502 |
| Metabolic syndrome, ALAD | 29.3% | 1.70% | 26.1% | 32.7% | 0.057 | 1.394 |
| Abdominal obesity | 47.8% | 1.30% | 45.2% | 50.3% | 0.027 | 1.847 |
| High triglyceride level | 44.1% | 2.30% | 39.6% | 48.7% | 0.053 | 2.361 |
| Low HDL cholesterol level | 42.6% | 2.10% | 38.6% | 46.8% | 0.049 | 1.914 |
| Hypertension | 28.3% | 1.00% | 26.3% | 30.4% | 0.037 | 1.519 |
| Abnormal fasting glucose level | 11.2% | 1.30% | 8.9% | 14.0% | 0.116 | 1.809 |
[i] Source: authors.
[ii] Note: ATP III, Adult Treatment Panel III; ALAD, Latin American Diabetes Association; HDL, high‑density lipoprotein.
Table 3
Prevalence of type 2 diabetes and metabolic syndrome in the population aged ≥18 years in Bogotá, Colombia, 2022–2023.
| UNADJUSTED | ADJUSTED | |||||
|---|---|---|---|---|---|---|
| PR | 95% CI | P VALUE | PR | 95% CI | P VALUE | |
| Female | 1.14 | (0.80–1.62) | 0.481 | 1.39 | (0.96–2.04) | 0.080 |
| Age, years | ||||||
| <45 (ref.) | 1 | 1 | ||||
| 45–54.9 | 2.78 | (1.06–7.29) | 0.038 | 2.58 | (0.99–6.74) | 0.053 |
| 55–64.9 | 5.48 | (2.29–13.2) | <0.001 | 4.46 | (1.79–11.15) | 0.001 |
| ≥65 | 10.47 | (4.43–24.8) | <0.001 | 5.89 | (2.42–14.30) | <0.001 |
| Abdominal obesity | 3.30 | (2.32–4.68) | <0.001 | 2.00 | (1.33–3.03) | 0.001 |
| High triglyceride level | 2.22 | (1.60–3.09) | <0.001 | 1.69 | (1.18–2.43) | 0.005 |
| SE stratum | ||||||
| Medium or higher (ref.) | 1 | |||||
| Low/very low | 1.62 | (1.11–2.36) | 0.012 | |||
| Household Income | ||||||
| >3 SMLV | 1 | |||||
| 3 SMLV | 1.15 | (0.20–6.51) | 0.874 | |||
| 2 SMLV | 1.72 | (0.62–4.78) | 0.298 | |||
| 1 SMLV | 1.65 | (0.60–4.55) | 0.330 | |||
| <1 SMLV | 2.64 | (0.92–7.56) | 0.071 | |||
| Education level | ||||||
| University (ref.) | 1 | 1 | ||||
| Technical | 0.86 | (0.28–2.64) | 0.796 | 0.94 | (0.29–3.06) | 0.919 |
| Secondary | 1.74 | (0.73–4.17) | 0.212 | 1.41 | (0.55–3.62) | 0.470 |
| Primary | 4.58 | (1.88–11.15) | 0.001 | 2.23 | (0.87–5.74) | 0.096 |
| None | 7.38 | (2.50–21.82) | <0.001 | 3.38 | (1.07–10.70) | 0.038 |
| Healthcare regimen | ||||||
| Contributive | 1 | |||||
| Subsidized | 1.28 | (0.89–1.83) | 0.174 | |||
| Uninsured/unknown | 0.33 | (0.09–1.19) | 0.091 | |||
[i] Source: authors.
[ii] Note: SMLV, monthly minimum wage; CI, confidence interval; PR, prevalence ratio; SE, socioeconomic.
Table 4
Variables associated with the prevalence of type 2 diabetes in Bogota, 2022–2023: crude and adjusted regression models.
| ATP III | ALAD | |||||||
|---|---|---|---|---|---|---|---|---|
| VARIABLES | UNADJUSTED | ADJUSTED | UNADJUSTED | ADJUSTED | ||||
| PR | 95% CI | PR | 95% CI | PR | 95% CI | PR | 95% CI | |
| Female | 3.19 | (2.44–4.16) | 3,30 | (2.49–4.36) | 2.14 | (1.62–2.83) | 2.29 | (1.71–3.08) |
| Age, years | ||||||||
| <45 (ref.) | 1 | 1 | 1 | 1 | ||||
| 45–54.9 | 1.26 | (0.88–1.80) | 1.43 | (0.99–2.06) | 1.02 | (0.66–1.57) | 1.04 | (0.65–1.67) |
| 55–64.9 | 0.89 | (0.64–1.25) | 1.08 | (0.75–1.56) | 1.05 | (0.71–1.57) | 1.13 | (0.74–1.73) |
| ≥65 | 1.32 | (0.89–1.97) | 1.16 | (0.80–1.69) | 1.65 | (1.16–2.35) | 1.43 | (0.98–2.10) |
| SE stratum | ||||||||
| Medium or higher (ref.) | 1 | 1 | ||||||
| Low/very low | 1.14 | (0.80–1.62) | 1.26 | (0.95–1.67) | ||||
| Household income | ||||||||
| >3 SMLV | 1 | 1 | ||||||
| 3 SMLV | 0.51 | (0.17–1.48) | 0.80 | (0.19–3.42) | ||||
| 2 SMLV | 0.45 | (0.18–1.14) | 1.97 | (0.88–4.42) | ||||
| 1 SMLV | 0.85 | (0.41–1.76) | 3.33 | (1.42–7.78) | ||||
| <1 SMLV | 0.79 | (0.34–1.85) | 2.77 | (1.16–6.59) | ||||
| Education level | ||||||||
| University (ref.) | 1 | 1 | 1 | 1 | ||||
| Technical | 0.38 | (0.22–0.66) | 0.45 | (0.26–0.80) | 0.64 | (0.38–1.08) | 0.69 | (0.39–1.24) |
| Secondary | 0.89 | (0.62–1.27) | 1.00 | (0.69–1.46) | 1.20 | (0.79–1.82) | 1.27 | (0.84–1.91) |
| Primary | 1.35 | (0.90–2.03) | 1.61 | (1.16–2.25) | 2.04 | (1.41–2.94) | 2.02 | (1.38–2.95) |
| None | 1.11 | (0.54–2.28) | 1.13 | (0.52–2.47) | 1.34 | (0.62–2.90) | 1.07 | (0.46–2.52) |
| Healthcare regimen | ||||||||
| Contributive | 1 | 1 | 1 | 1 | ||||
| Subsidized | 0.86 | (0.65–1.13) | 0.79 | (0.60–1.02) | 1.11 | (0.85–1.45) | 0.94 | (0.71–1.24) |
| Uninsured/unknown | 1.99 | (1.37–2.89) | 2.19 | (1.48–3.23) | 1.43 | (0.72–2.84) | 1.50 | (0.83–2.71) |
[i] Source: authors.
[ii] Note: SMLV, monthly minimum wage; CI, confidence interval; ATP III, Adult Treatment Panel III (14); ALAD, Latin American Diabetes Association (17); PR, prevalence ratio; SE, socioeconomic.
[iii] Crude and adjusted prevalence ratios of metabolic syndrome in associated variables, according to the ATP III and ALAD criteria, in Bogota, 2022–2023.